Headlines about Health Insurance Innovations (NASDAQ:HIIQ) have been trending somewhat positive on Sunday, Accern reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Health Insurance Innovations earned a news impact score of 0.18 on Accern’s scale. Accern also assigned press coverage about the financial services provider an impact score of 45.7191537466115 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Here are some of the news stories that may have effected Accern’s analysis:
- Health Insurance Innovations’ (HIIQ) CEO Gavin Southwell on Q2 2017 Results - Earnings Call Transcript (seekingalpha.com)
- Health Insurance Innovations, Inc. (HIIQ) Expected to Announce Quarterly Sales of $52.06 Million (americanbankingnews.com)
- Top-Rated Stocks: Health Insurance Innovations Sees Composite Rating Climb To 97 (investors.com)
- Health Insurance Innovations, Inc. (NASDAQ:HIIQ) Upgraded to “Buy” at Zacks Investment Research (americanbankingnews.com)
- AO Signal in Focus For Health Insurance Innovations Inc (HIIQ) - Evergreen Caller (evergreencaller.com)
A number of analysts recently weighed in on HIIQ shares. Zacks Investment Research cut shares of Health Insurance Innovations from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 3rd. Cantor Fitzgerald restated an “overweight” rating and set a $35.00 target price (up from $30.00) on shares of Health Insurance Innovations in a report on Monday, July 17th. Raymond James Financial, Inc. restated a “market perform” rating on shares of Health Insurance Innovations in a report on Monday, June 26th. Craig Hallum started coverage on shares of Health Insurance Innovations in a report on Monday, June 12th. They set a “buy” rating and a $28.00 target price for the company. Finally, TheStreet upgraded shares of Health Insurance Innovations from a “c” rating to a “b-” rating in a research report on Monday, May 22nd. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $30.83.
Health Insurance Innovations (NASDAQ HIIQ) traded up 7.09% on Friday, hitting $31.70. 911,774 shares of the stock were exchanged. The stock has a market capitalization of $399.42 million, a P/E ratio of 28.30 and a beta of 0.68. The company has a 50 day moving average of $25.25 and a 200 day moving average of $20.08. Health Insurance Innovations has a one year low of $3.90 and a one year high of $32.95.
Health Insurance Innovations (NASDAQ:HIIQ) last posted its quarterly earnings results on Wednesday, August 2nd. The financial services provider reported $0.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.33 by $0.13. Health Insurance Innovations had a net margin of 5.56% and a return on equity of 23.92%. The firm had revenue of $61.80 million for the quarter, compared to analyst estimates of $53.69 million. Health Insurance Innovations’s revenue for the quarter was up 38.9% compared to the same quarter last year. On average, equities research analysts forecast that Health Insurance Innovations will post $1.48 earnings per share for the current fiscal year.
In other news, CFO Michael D. Hershberger sold 15,000 shares of the stock in a transaction dated Tuesday, May 9th. The shares were sold at an average price of $20.37, for a total value of $305,550.00. Following the transaction, the chief financial officer now directly owns 93,369 shares of the company’s stock, valued at $1,901,926.53. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sheldon Wang sold 12,417 shares of the stock in a transaction dated Friday, May 12th. The shares were sold at an average price of $21.18, for a total transaction of $262,992.06. Following the completion of the transaction, the insider now directly owns 226,251 shares in the company, valued at $4,791,996.18. The disclosure for this sale can be found here. Insiders have sold 256,983 shares of company stock worth $6,283,895 over the last ninety days. Insiders own 30.00% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was first reported by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at https://stocknewstimes.com/2017/08/06/health-insurance-innovations-nasdaqhiiq-receives-news-sentiment-score-of-0-18-updated-updated.html.
Health Insurance Innovations Company Profile
Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.
Receive News & Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
